P.072 Safety and effectiveness of Nipocalimab in adolescent participants in the open label phase 2/3 Vibrance-mg clinical study. Read more about P.072 Safety and effectiveness of Nipocalimab in adolescent participants in the open label phase 2/3 Vibrance-mg clinical study.